This is the authors' abstract. We don't add key points for this paper.
Eradication of Helicobacter pylori usually consists of a 7-day course of triple therapy including metronidazole or amoxicillin plus clarithromycin plus a proton pump inhibitor. We report about a rare adverse event of Hp eradication in a patient with moderate chronic and moderate active pangastritis. Shortly after the end of treatment cholestatic hepatitis occurred which was most likely related to clarithromycin, perhaps enhanced by amoxicillin. Since liver dysfunction was self-limited, no further treatment was required. In summary, clinicians should be aware about the presented rare adverse event of Helicobacter pylori eradication treatment for a close monitoring of those patients and rapid management of acute liver failure.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wiedmann et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: